This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Rare disease-focused Therachon AG raised $60mm in a mezzanine financing led by Novo Holdings, which was joined by other new backers Cowen Healthcare Investments, Pfizer Ventures, and Tekla Capital Management, and returning shareholders OrbiMed, Bpifrance, and Inserm Transfert Initiative. A representative from Novo and Cowen join the board. Therachon will use the funds for ongoing development of its pipeline including lead candidate Phase I TA46 for achondroplasia.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?